Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nutex HealthFRA:5LF +3.77%57 Net Margin % is 31.24% as of Jun. 2026, which is 188% above its 10-year median of 10.85. GuruFocus rates FRA:5LF with a GF Score™ of 57/100 and a GF Value™ of €70.29 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 670 Healthcare Providers & Services companies, Nutex Health ranks better than 94.63% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Nutex Health's Net Income for the
three
months ended in Jun. 2026 was €57.2 Mil. Nutex Health's Revenue for the
three
months ended in Jun. 2026 was €182.9 Mil. Therefore, Nutex Health's net margin for the quarter that ended in Jun. 2026 was 31.24%.
The historical rank and industry rank for Nutex Health's Net Margin % or its related term are showing as below:
FRA:5LF'
s Net Margin % Range Over the Past 10 Years
Min: -193.7 Med: 10.85 Max: 39.99
Current: 21.25
FRA:5LF's Net Margin % is ranked better than 94.63% of 670
companies
in the Healthcare Providers & Services industry
Industry Median: 2.81
vs FRA:5LF: 21.25
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Nutex Health Net Margin % Related Terms
Nutex Health Net Margin % Historical Data
* Premium members only.
The historical data trend for Nutex Health's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:5LF vs USPH, AMN, GMRS: Net Margin % Comparison
For the Medical Care Facilities subindustry, Nutex Health's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutex Health Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's Net Margin % distribution charts can be found below:
* The bar in red indicates where Nutex Health's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nutex Health (FRA:5LF) has a Net Margin % of 31.24% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Nutex Health and its competitors. This is 188% above median its historical median of 10.85. According to the industry distribution chart, Nutex Health ranks #36 out of 670 companies in the Healthcare Providers & Services industry, placing it in the top 5.4%.
Is Nutex Health's Net Margin % too high?
Nutex Health's current Net Margin % of 31.24% is 188% above median its 10-year median of 10.85. The Healthcare Providers & Services industry median Net Margin % is 2.81. Nutex Health's value of 31.24% is 1011.7% above this industry median. Based on the distribution chart, Nutex Health ranks #36 out of 670 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Nutex Health has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nutex Health's Net Margin % compare to USPH and AMN?
According to the Healthcare Providers & Services industry distribution chart, Nutex Health ranks #36 out of 670 companies for Net Margin %. This places Nutex Health in the top 5% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.81. Nutex Health's value of 31.24% is 1011.7% above this benchmark. While the company's 10-year median is 10.85 vs. the industry median of 2.81, Nutex Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.81, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nutex Health's current Net Margin % of 31.24% is 1011.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Nutex Health and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nutex Health's current Net Margin % is 31.24%, which is 188% above median its own 10-year median of 10.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutex Health stock overvalued right now?
Based on GuruFocus' analysis, Nutex Health (FRA:5LF) is currently considered Significantly Overvalued. The stock's GF Value™ is €70.29, compared to a current price of €165.00 — trading 134.7% above its estimated fair value. The current Net Margin % is 31.24%, which is 188% above median its 10-year median of 10.85 and 1011.7% above the Healthcare Providers & Services industry median of 2.81. Nutex Health's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Nutex Health (FRA:5LF), the current Net Margin % is 31.24% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nutex Health (FRA:5LF) Overvalued in 2026?
Based on GuruFocus' analysis, Nutex Health stock appears to be overvalued.
The current stock price of €165.00 is trading 134.7% above its estimated GF Value™ of €70.29.
GuruFocus considers Nutex Health to be Significantly Overvalued.
Key valuation signals for FRA:5LF:
Net Margin %: 31.24% (188% above median its 10-year median of 10.85)
GF Value™: €70.29 vs. price of €165.00 (134.7% above fair value)
Industry Position: 1011.7% above the Healthcare Providers & Services median (#36 of 670)
No single metric tells the full story. See the FRA:5LF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
57GF Score
Get the complete analysis for FRA:5LF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5LF has been successfully added to your 
